Speaker illustration

Mr Andreas Blomqvist

Linkoping University, Linkoping (Sweden)

Member of:

European Society of Cardiology

Andreas Blomqvist, MSc, MBA, is the co-founder and V.P of Research and Development at CareLigo AB. Andreas has previously been working with heart failure research at St. Jude Medical, doing clinical research in Sweden, Germany and the United States. He is curently leading the development of CareLigos mHealth-solution OPTILOGG, as it is launched on the Scandinavian markets and at the same time pursuing his PhD in medicine at Linkoping University, Sweden.

The heart failure activity coach study -a pilot randomised controlled trial

Event: Heart Failure 2024

Topic: Remote Patient Monitoring and Telehealth

Session: e-Cardiology/digital health - remote patient monitoring and telehealth

Thumbnail

An mHealth-tool for supporting physical activity in patients with heart failure

Event: Heart Failure 2022

Topic: Lifestyle Modification

Session: Heart Failure ePosters - focus on Chronic Heart Failure 8

Thumbnail

Using mHealth to reduce heart failure related in-hospital care -a meta-analysis

Event: Heart Failure 2022

Topic: Remote Patient Monitoring and Telehealth

Session: Heart Failure ePosters - focus on Pharmacology and other topics

Thumbnail

Effect of flexible diuretics regimen on sudden weight changes

Event: ESC Congress 2018

Topic: Lifestyle Modification

Session: Chronic heart failure – treatment

Thumbnail

OPTILOGG.

Event: ESC Congress 2018

Topic: e-Cardiology/Digital Health

Session: Best of Apps

Thumbnail

ESC 365 is supported by